Neil Lerner, Chief Accounting Officer at Compass Therapeutics, Inc. (CMPX), bought 20,000 shares at $0.92 ($18K) on 2026-10-01, disclosed to the SEC on 2026-10-02.
Chief Accounting Officer Neil Lerner purchased $18,400 of CMPX stock at $0.92, marking the largest insider purchase in the company's history. This rare signal comes as the stock has collapsed over 75% in the last year, potentially signaling a bottom for the biotech name.
CMPX is trading at $0.8545, down 24.04% over the last 5 days and 64.98% over the last 30 days. The stock is currently 87.58% below its 52-week high of $6.88 and sits just 3.03% above its 52-week low of $0.8294.
Insider purchased the largest amount of shares in company history on Oct 1, 2026; stock is trading near 52-week lows at $0.8545.
The stock has a short interest of 27.65% of the float, indicating significant bearish sentiment and potential volatility.
Something here stands out, but not much.